CClinicalTrials.gg
Status unknownNCT01200745Updated Sep 14, 2010

Efficacy of Topical Capsaicin on Chronic Neck Pain

An interventional study of Capsaicin patch in Chronic Neck Pain, sponsored by Kyunghee University Medical Center. Status unknown at 1 site in Korea, Republic of. Open to participants aged 18 Years to 65 Years. Per ClinicalTrials.gov, last updated 2010-09-14.

Sponsored by Kyunghee University Medical Center · Not applicable, Interventional, and Treatment

The sponsor has not verified this record recently (last verified Sep 2010), so the status shown — last known as Not yet recruiting — may be out of date.
Phase
Not applicable
Study type
Interventional
Enrollment
60
Allocation
Randomized
Ages
18 Years to 65 Years
Sex
All
01

Study summary

The purpose of this study is to determine whether topical capsaicin patch can effectively reduce chronic neck pain.

Read the detailed description
  • Design: This is a double-blind, randomized, controlled study. Participants: Sixty participants with chronic neck pain are recruited and randomly assigned to two groups.
  • Intervention: Over an four-week period, the treatment group (n=30) uses capsaicin patch (100 mcg/3cc) at the tender point of neck for 12 hours a day; the control group (n=30) receives Hydrogel patch instead of capsaicin patch.
02

Conditions studied

  • Chronic Neck Pain

Browse trials for

Keywords

  • neck pain
  • capsaicin
  • dermal patch
03

In context

Neck Pain

1,231 studies on the registry are indexed under Neck Pain; 254 are open to participants now.

This study's planned enrollment of 60 is above the median of 52 across 1,004 interventional studies indexed under Neck Pain.

Browse Neck Pain studies →

Lead sponsor

Kyunghee University Medical Center is the lead sponsor of 62 studies on the registry; 5 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Korean participants with Chronic neck pain are enrolled in our study

Exclusion criteria

Exclusion Criteria:

  • Participants with coagulation deficiencies, infections, hypertension, diabetes, heart disease, renal disease, liver disease, cancer, myelopathy, hypersensitivity of drugs, other skeletomuscular disease, allergic response to capsaicin, pregnancy and nursing are excluded
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Triple (Participant, Investigator, Outcomes assessor)
Enrollment
60 participants (estimated)

Study arms

  • Active comparator
    capsaicin patch

    Drug: Capsaicin patch

  • Placebo comparator
    Hydrogel patch

    Drug: Capsaicin patch

Interventions

  • DrugCapsaicin patch

    Over an four-week period, the treatment group (n=30) uses capsaicin patch (100 mcg/3cc) at the tender point of neck for 12 hours a day; the control group (n=30) receives Hydrogel patch instead of capsaicin patch.

    Also known as: Hydrogel Patch

06

What researchers measure

Primary outcomes

  1. Pain Scores on the Visual Analogue Scale(VAS)

    Time frame: 4 week

Secondary outcomes

  1. Neck disability index

    Neck disability index : questionnaire for measuring how much neck pain affects ability of daily activities

    Time frame: 4 week

  2. Beck depression inventory

    Beck depression inventory : for assessing depression

    Time frame: 4 week

  3. SF-36

    questionnaire for measuring health-related quality of life

    Time frame: 4 week

  4. EQ-5D(EuroQol-5 dimension)

    questionnaire for measuring health-related quality of life

    Time frame: 4 week

07

Study locations

1 site
  • Kyunghee University East West Neo Medical Center
    Seoul, 134-727, Korea, Republic of
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Sep 14, 2010, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT01200745
Lead sponsor
Kyunghee University Medical Center
First posted
Sep 14, 2010
Start date
Sep 2010
Primary completion
Jan 2011 (estimated)
Completion
Feb 2011 (estimated)
Last update
Sep 14, 2010

Study contacts

Yu-Jeong Cho
Contact
jamyunghwa@hotmail.com
+82-2-440-7575
Mi-Yeon Song, OMD, PhD
principal investigator · Department of Oriental Rehabilitation Medicine/College of Oriental Medicine/Kyung Hee University

Oversight

Data monitoring committee
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Sep 2010. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion